Medifast, Inc.
MED
$12.57
$0.171.37%
NYSE
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -2.12M | -18.12M | -2.26M | 2.48M | -772.00K |
| Total Depreciation and Amortization | 3.48M | 3.47M | 3.45M | 4.05M | 3.28M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 812.00K | 15.65M | 1.86M | 925.00K | 2.67M |
| Change in Net Operating Assets | -1.91M | -6.28M | 9.07M | -10.83M | -1.77M |
| Cash from Operations | 260.00K | -5.28M | 12.11M | -3.38M | 3.41M |
| Capital Expenditure | -1.10M | -1.35M | -1.36M | -1.38M | -1.52M |
| Sale of Property, Plant, and Equipment | 3.64M | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -19.67M | -3.60M | -12.92M | 14.74M | -532.00K |
| Cash from Investing | -17.13M | -4.95M | -14.28M | 13.36M | -2.05M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | 1.00K | -- | -- | -- |
| Repurchase of Common Stock | -814.00K | -- | 0.00 | -1.00K | -369.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -87.00K | 0.00 | 0.00 | -1.00K | -194.00K |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -901.00K | 1.00K | 0.00 | -2.00K | -563.00K |
| Foreign Exchange rate Adjustments | -- | 4.00K | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -17.77M | -10.22M | -2.17M | 9.98M | 789.00K |